Cooperative Agreement U01EB036001
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $727,680 Cooperative Agreement under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Illinois. The goal of this 3-year project is to develop an advanced brain SPECT (single-photon emission computed tomography) system that offers hyperspectral imaging capabilities with excellent energy resolution. This research aims to transform...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $459,264 Project Grant to The Johns Hopkins University under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, which runs from Apr 8, 2025 to Feb 28, 2029, will support research and development to enhance resolution and contrast in magnetic resonance (MR) neuroimaging. This is intended to help standardize the appearance of MR neuroimages...
- This federal Project Grant award for $641,360 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop a digitally programmable and versatile radio frequency (RF) coil for ultra-high-field brain magnetic resonance imaging (MRI) at 7 Tesla. The award will support the creation of an "Any-Nucleus Distributed Active Programmable Transmit...
- This Cooperative Agreement award from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) provides $808,070 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a novel head-neck imaging system for comprehensive neurological MRI exams at 7 Tesla. The project aims to create a 16-channel transmit/64-channel receive radiofrequency coil...
- This Cooperative Agreement award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $3,044,814.00 to the University of California, Irvine to develop a high-speed, multimodal deep tissue imaging system. The key products and services to be delivered under this 2-year award (9/1/2025 - 8/31/2027) include: Developing a reflection matrix-based wavefront shaping system to overcome light scattering limitations and achieve real-time,...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,161,839 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Wisconsin System for the project "MRI Technology for Greater Efficiency and Improved Value". The overall goal is to design technologies that improve the value of MRI by enhancing efficiency, accessibility, safety, and user experience. Key...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $390,616 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the Regents of the University of Michigan for the development of layer-specific functional magnetic resonance imaging (fMRI) techniques for clinical 3 Tesla scanners. The goal is to improve signal-to-noise ratio and reduce scan time for layer-specific fMRI, which currently...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded a $306,203 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Resonance Research Inc. The grant, awarded on September 1, 2024, supports the development of an advanced, digitally-controlled multiband shimming system for improved neuroimaging using high-field magnetic resonance imaging (MRI) scanners. The goal is to create a...
- The federal Project Grant award R56EB033347, in the amount of $499,291.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The award will support the development of breakthrough technology to enable future compact, mid-field (0.7 Tesla) magnetic resonance imaging (MRI) systems, with the goal of improving accessibility and...
- The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (dMRI) technologies. This funding will enable MGH to create novel acquisition methods that can provide significant...
This Cooperative Agreement award, valued at $700,067.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) federal grant program. The primary goal of this project is to develop and validate a new magnetic resonance-based multimodal imaging technology that can simultaneously acquire a large set of molecular and tissue property biomarkers from the whole brain in high spatial resolution and imaging speed. The project team, consisting of researchers from the University of Illinois at Urbana-Champaign, Yale University, Emory University, Johns Hopkins University, and Siemens Healthineers, will collaborate to develop a next-generation magnetic resonance spectroscopic imaging (MRSI) data acquisition sequence for simultaneous multimodal imaging, a machine learning-assisted data processing pipeline, and conduct a multisite experimental study to evaluate the performance and clinical potential of the proposed multimodal imaging technology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $700.1k | 7/31/25 |